| COVID-19 pandemic effects on breast cancer diagnosis in Croatia: A population-and registry-based study E Vrdoljak, MP Balja, Z Marušić, M Avirović, V Blažičević, Č Tomasović, ... The oncologist 26 (7), e1156-e1160, 2021 | 36 | 2021 |
| EGFR expression is linked to osteopontin and Nf-κB signaling in clear cell renal cell carcinoma K Matušan-Ilijaš, G Damante, D Fabbro, G Đorđević, I Hadžisejdić, ... Clinical and Translational Oncology 15, 65-71, 2013 | 29 | 2013 |
| Osteopontin is associated with decreased apoptosis and αv integrin expression in lung adenocarcinoma C Štemberger, K Matušan-Ilijaš, M Avirović, L Bulat-Kardum, A Ivančić, ... Acta histochemica 116 (1), 222-229, 2014 | 27 | 2014 |
| Osteopontin expression is an independent factor for poor survival in oral squamous cell carcinoma: a computer‐assisted analysis on TMA sections M Avirović, K Matušan‐Ilijaš, G Damante, D Fabrro, R Cerović, M Juretić, ... Journal of oral pathology & medicine 42 (8), 620-626, 2013 | 16 | 2013 |
| Applying explainable machine learning models for detection of breast cancer lymph node metastasis in patients eligible for neoadjuvant treatment J Vrdoljak, Z Boban, D Barić, D Šegvić, M Kumrić, M Avirović, ... Cancers 15 (3), 634, 2023 | 9 | 2023 |
| Nuclear EGFR expression is associated with poor survival in laryngeal carcinoma B Marijić, T Braut, E Babarović, M Krstulja, D Maržić, M Avirović, ... Applied immunohistochemistry & molecular morphology 29 (8), 576-584, 2021 | 8 | 2021 |
| The expression of calpain-1 and androgen receptor in breast cancer and their correlation with clinicopathological characteristics: An immunohistochemical retrospective study K Rajković-Molek, E Mustać, M Avirović, P Georgev, M Demaria, J Aničić, ... Pathology-Research and Practice 216 (9), 153068, 2020 | 7 | 2020 |
| IMP3 protein overexpression is linked to unfavorable outcome in laryngeal squamous cell carcinoma D Maržić, B Marijić, T Braut, S Janik, M Avirović, I Hadžisejdić, F Tudor, ... Cancers 13 (17), 4306, 2021 | 6 | 2021 |
| Clinical impact of sentinel lymph node biopsy after neoadjuvant systemic treatment in luminal B, HER-2 positive and triple-negative breast cancer patients with initially … A Car Peterko, M Avirović, D Mance, P Valković Zujić, I Belac Lovasić, ... Libri oncologici: Croatian journal of oncology 47 (1), 29-39, 2019 | 6 | 2019 |
| The expression of ribonuclear protein IMP3 in laryngeal carcinogenesis D Maržić, M Čoklo, B Marijić, I Hadžisejdić, A Dekanić, M Krstulja, T Šepić, ... Pathology-Research and Practice 216 (6), 152974, 2020 | 5 | 2020 |
| Impact of HER2 receptor status on axillary nodal burden in patients with non-luminal A invasive ductal breast carcinoma D Kustić, I Lovasić, Franjo, Belac-Lovasić, M Avirović, ... Revista medica de Chile 147 (5), 557-567, 2019 | 4 | 2019 |
| Smjernice Hrvatskoga onkološkog društva za dijagnozu, liječenje i praćenje bolesnica/ka oboljelih od invazivnog raka dojke (HOD RD-3) I Belac Lovasić, M Bašić Koretić, P Podolski, N Dedić Plavetić, T Silovski, ... Liječnički vjesnik 144 (9-10), 295-305, 2022 | 2 | 2022 |
| Utjecaj pandemije COVID-19 na rad patologije i citologije u Kliničkom bolničkom centru Rijeka D Vrdoljak Mozetič, A Savić Vuković, M Avirović, I Seili Bekafigo, ... Liječnički vjesnik 143 (3-4), 81-89, 2021 | 2 | 2021 |
| Clinical Impact of Sentinel Lymph Node Biopsy after Neoadjuvant Treatment in Breast Cancer Patients with Initially Involved Axillary Lymph Nodes (Single-Center Experience) AC Peterko, M Avirović, D Mance, PV Zujić, IB Lovasić, F Lovasić European Journal of Surgical Oncology 46 (2), e38-e39, 2020 | 2 | 2020 |
| Differences in tolerogenic status of NK cells between luminal A type, luminal B type, and triple-negative breast cancer. A Starčević, D Grebić, M Avirović, M Mavrinac, PV Zujić, DV Vujaklija, ... Neoplasma 69 (6), 2022 | 1 | 2022 |
| Clinical guidelines for diagnosis, treatment and monitoring of patients with invasive breast cancer–Croatian Oncology Society (BC-3 COS) I Belac Lovasić, M Bašić Koretić, P Podolski, N Dedić Plavetić, T Silovski, ... Liječnički vjesnik 144 (9-10), 295-305, 2022 | 1 | 2022 |
| HSP70 In triple negative breast cancer: Prognostic value and clinical significance AC Peterko, K Rajković-Molek, T Gulić, DV Vujaklija, IB Lovasić, F Lovasić, ... Pathology-Research and Practice 238, 154127, 2022 | 1 | 2022 |
| Clinical relevance of natural killer cells in breast cancer T Gulić, D Grebić, A Starčević, M Avirović, P Valković Zujić, ... Medicina Fluminensis 58 (2), 113-120, 2022 | 1 | 2022 |
| Overall survival and disease control rates for operable invasive breast cancer in the era of conservative surgery; retrospective, institutional, and five-year follow-up data A Car-Peterko, M Avirović, I Skočilić, P Valković-Zujić, I Belac-Lovasić, ... Libri oncologici: Croatian journal of oncology 48 (2-3), 61-67, 2020 | 1 | 2020 |
| PD-L1 and HSP-70 molecules are part of immunosupressive environment in the deep layer of the lymphocyte predominant breast cancer (LPBC) AC Peterko, KR Molek, DV Vujaklija, PZ Valković, IB Lovasić, F Lovasić, ... European journal of cancer 138, S22-S23, 2020 | 1 | 2020 |
